Japer Therapeutics Warrants
JSPRW
14 hedge funds and large institutions have $179K invested in Japer Therapeutics Warrants in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
7% less funds holding
Funds holding: 15 → 14 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
68% less capital invested
Capital invested by funds: $554K → $179K (-$375K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$6.33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$4K |
| 2 |
ICMH
Integrity Capital Management (HK)
Central,
Hong Kong
|
-$2K |
| 3 |
HF
HRT Financial
New York
|
-$530 |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$58 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HCM
1
Highbridge Capital Management
New York
| $48K | – | – | – |
|
|
OCAM
2
Owl Creek Asset Management
New York
| $34K | – | – | – |
|
|
ICM
3
Ionic Capital Management
New York
| $33K | – | – | – |
|
|
TCM
4
Tenor Capital Management
New York
| $23K | – | – | – |
|
|
SCM
5
Shaolin Capital Management
Miami,
Florida
| $12K | – | – | – |
|
|
PFM
6
Privium Fund Management
Amsterdam,
Netherlands
| $9K | – | – | – |
|
|
ZA
7
Zazove Associates
Incline Village,
Nevada
| $7K | – | – | – |
|
|
EPM
8
Equitec Proprietary Markets
Chicago,
Illinois
| $4K | – | – | – |
|
|
HF
9
HRT Financial
New York
| $3K | -$530 | -2,729 | -7% |
|
|
CAC
10
Cowen and Company
New York
| $3K | +$6.33K | +32,590 | New |
|
11
Walleye Capital
New York
| $2K | – | – | – |
|
12
Walleye Trading
New York
| $1K | – | – | – |
|
|
YCM
13
Yakira Capital Management
Westport,
Connecticut
| – | -$4K | -11,705 | Closed |
|
|
ICMH
14
Integrity Capital Management (HK)
Central,
Hong Kong
| – | -$2K | -5,439 | Closed |
|
|
15
UBS Group
Zurich,
Switzerland
| – | -$58 | -300 | -8% |
|
JSPRW Hedge Fund Activity: Q2 2022 in Review
14 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q2 2022, worth a combined $179K — down 68% from $554K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of JSPRW and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest buyer was Cowen and Company, opening a new position worth an estimated $6.33K. The largest seller was Yakira Capital Management, exiting entirely with an estimated $4K sold.
- 14 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q2 2022, down from 15 in Q1 2022.
- Funds reported $179K of Japer Therapeutics Warrants stock for Q2 2022, down 68% quarter-over-quarter.
- 1 fund opened new Japer Therapeutics Warrants positions in Q2 2022 and 2 closed out, a net change of -1 holder.
- The largest Japer Therapeutics Warrants buyer in Q2 2022 was Cowen and Company, an estimated $6.33K added.
- The largest Japer Therapeutics Warrants seller in Q2 2022 was Yakira Capital Management, an estimated $4K sold.
Based on aggregated 13F filings for Q2 2022.